Accrol Group “holds a strategically important position in the industry” says Zeus Capital

Accrol Group Holdings plc (LON:ACRL) has released H1 results, which are 7% below last year’s level at the adjusted EBITDA level at £5.0m despite significant supply chain disruption and cost escalation. We made our earnings adjustments in the trading update last week but reduce our net debt forecasts by 13% to £23.9m reflecting lower capital expenditure investment. We believe more can be done to reduce this through working capital efficiencies, but we have left our assumptions on this unchanged for now.

  • H1 results: Revenue growth of 18.3% YOY reflected the successful scaling and integration of LTC and John Dale, while gross margins also improved YOY despite raw material cost increases. Adjusted EBITDA at £5.0m was just 6.7% below last year despite the impact of supply chain issues. Adjusted PBT was £0.7m vs. £2.6m last year primarily due to a £1.5m YOY increase in depreciation and a £0.3m increase in net finance costs.
  • Margin management: A clear plan has been put in place to offset c£45-50m of input cost pressures. Clearly the main variable we are dealing with on this is timing. The cost headwinds will continue to come through as pulp and paper prices continue to climb driven by energy costs, while global shipping issues will take at least 12 months to resolve. That said, c£45m of annualised priced have already been largely agreed. In addition, management are working on £3-5m of annualised efficiencies to further offset the effect of escalating costs.
  • Outlook:  Volumes are said to be returning to normal with private label now back in growth progressing month on month. Operational improvements on track with the final automation of the Leyland site to complete by the end of March 2022, which, alongside the final machine installation, will complete the major investment into Accrol Group’s Tissue business.
  • Forecasts: We maintain our earnings forecasts following the trading update last week. However, we have adjusted our net debt forecasts down in 2022E to reflect lower levels of capital expenditure (down from £8m to £5m). We would anticipate management seeking to find further working capital efficiencies at this juncture too but have not revised our forecasts at this stage. Our assumptions for FY23 and FY24 remain unchanged but fall on the back, in absolute terms, of the FY22 position.
  • Valuation: The impact of the recent sharp input cost inflation on near term profitability is undoubtedly disappointing, with the Group unable to enact mitigating price rises in the near term. Despite this, we believe Accrol Groupholds a strategically important position in the industry, and in its current form can generate c.£250m in revenue and >£30m EBITDA over the medium term.
Click to view all articles for the EPIC: ,
Or click to view the full company profile:
Share on facebook
Share on twitter
Share on linkedin
Accrol Group Holdings plc

More articles like this

Accrol Group

Resilient year at toilet roll maker

A listed business which produces toilet roll, kitchen roll, facial tissue and wet wipe products for most of the UK’s major grocery retailers has reported full-year results covering a resilient performance despite “extremely challenging” macro conditions. Accrol Group

Accrol Group

Tissue maker confident as new financial year begins strongly

Accrol, the AIM-listed Blackburn-based tissue and toilet roll maker, said it is well positioned for the future, after announcing results for the year to April 30, 2022, today. Revenues increased from £136.6m in 2021 to £159.5m this year,

Accrol Group

Manufacturing trends in the UK

The pandemic hit the UK manufacturing scene just like everywhere else, and it has been scrambling to recover. Problems like supply chain disruptions, skill gaps, labor shortages, and the like have plagued the manufacturing industry in the UK amidst

Accrol Group

Employment in manufacturing continues to grow at a robust pace

Growth in manufacturing output and orders eased in the quarter to July, slowing to more typical rates of expansion following a period of exceptionally strong growth over the previous year. This is according to the latest CBI/Accenture Quarterly

Accrol Group

Accrol to expand with new Leyland unit

Blackburn-based paper products manufacturer Accrol is to expand its operation near Leyland with the build of a new 68,000 sq ft unit. Construction is underway at Lancashire Business Park in Farington and should be ready for occupation within a

Fintel plc

Fintel core revenue growth is higher than Zeus forecast

Fintel plc (LON:FNTL), the leading provider of Fintech and support services to the UK retail financial services sector, has released a trading update for the six months to 30 June 2022, which reveals: Core revenue grew c.9% to

Shoe Zone plc

Shoe Zone analyst Zeus upgrades FY22 adjusted PBT forecast

Shoe Zone plc (LON:SHOE) Better than expected demand and further strong margin performance leads to an upgrade in FY22E adjusted PBT from “no less than £8.5m” to “no less than £9.5m”. Zeus revenue forecasts increase by £1.5m (1.0%)

No more posts to show